Global Gynecological Cancer Diagnostics Supply, Demand and Key Producers, 2023-2029

Description

The global Gynecological Cancer Diagnostics market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report studies the global Gynecological Cancer Diagnostics demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Gynecological Cancer Diagnostics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gynecological Cancer Diagnostics that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Gynecological Cancer Diagnostics total market, 2018-2029, (USD Million)
Global Gynecological Cancer Diagnostics total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Gynecological Cancer Diagnostics total market, key domestic companies and share, (USD Million)
Global Gynecological Cancer Diagnostics revenue by player and market share 2018-2023, (USD Million)
Global Gynecological Cancer Diagnostics total market by Type, CAGR, 2018-2029, (USD Million)
Global Gynecological Cancer Diagnostics total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Gynecological Cancer Diagnostics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include UT Southwestern, Abramson Cancer Center, Northwestern Medicine, Sysmex Europe SE, Fujirebio, Premier Health, Agilent Technologies, Inc, ARUP Laboratories and CENTOGENE, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Gynecological Cancer Diagnostics market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Gynecological Cancer Diagnostics Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Gynecological Cancer Diagnostics Market, Segmentation by Type
    Genetic Counseling Test
    Cancer Risk Test
    Kits Test

Global Gynecological Cancer Diagnostics Market, Segmentation by Application
    Gestational Trophoblastic Disease Diagnostics
    Endometrial Cancer Diagnostics
    Peritoneal Cancer Diagnostics
    Cervical Cancer Diagnostics
    Ovarian Cancer Diagnostics
    Vaginal Cancer Diagnostics
    Uterine Cancer Diagnostics
    Vulvar Cancer Diagnostics

Companies Profiled:
    UT Southwestern
    Abramson Cancer Center
    Northwestern Medicine
    Sysmex Europe SE
    Fujirebio
    Premier Health
    Agilent Technologies, Inc
    ARUP Laboratories
    CENTOGENE
    F. Hoffmann-La Roche Ltd
    Fulgent Genetics, Inc
    Invitae Corporation
    Myriad Genetics, Inc
    BGI Group

Key Questions Answered
1. How big is the global Gynecological Cancer Diagnostics market?
2. What is the demand of the global Gynecological Cancer Diagnostics market?
3. What is the year over year growth of the global Gynecological Cancer Diagnostics market?
4. What is the total value of the global Gynecological Cancer Diagnostics market?
5. Who are the major players in the global Gynecological Cancer Diagnostics market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Gynecological Cancer Diagnostics Introduction
    1.2 World Gynecological Cancer Diagnostics Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Gynecological Cancer Diagnostics Total Market by Region (by Headquarter Location)
        1.3.1 World Gynecological Cancer Diagnostics Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Gynecological Cancer Diagnostics Market Size (2018-2029)
        1.3.3 China Gynecological Cancer Diagnostics Market Size (2018-2029)
        1.3.4 Europe Gynecological Cancer Diagnostics Market Size (2018-2029)
        1.3.5 Japan Gynecological Cancer Diagnostics Market Size (2018-2029)
        1.3.6 South Korea Gynecological Cancer Diagnostics Market Size (2018-2029)
        1.3.7 ASEAN Gynecological Cancer Diagnostics Market Size (2018-2029)
        1.3.8 India Gynecological Cancer Diagnostics Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Gynecological Cancer Diagnostics Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Gynecological Cancer Diagnostics Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Gynecological Cancer Diagnostics Consumption Value (2018-2029)
    2.2 World Gynecological Cancer Diagnostics Consumption Value by Region
        2.2.1 World Gynecological Cancer Diagnostics Consumption Value by Region (2018-2023)
        2.2.2 World Gynecological Cancer Diagnostics Consumption Value Forecast by Region (2024-2029)
    2.3 United States Gynecological Cancer Diagnostics Consumption Value (2018-2029)
    2.4 China Gynecological Cancer Diagnostics Consumption Value (2018-2029)
    2.5 Europe Gynecological Cancer Diagnostics Consumption Value (2018-2029)
    2.6 Japan Gynecological Cancer Diagnostics Consumption Value (2018-2029)
    2.7 South Korea Gynecological Cancer Diagnostics Consumption Value (2018-2029)
    2.8 ASEAN Gynecological Cancer Diagnostics Consumption Value (2018-2029)
    2.9 India Gynecological Cancer Diagnostics Consumption Value (2018-2029)

3 World Gynecological Cancer Diagnostics Companies Competitive Analysis
    3.1 World Gynecological Cancer Diagnostics Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Gynecological Cancer Diagnostics Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Gynecological Cancer Diagnostics in 2022
        3.2.3 Global Concentration Ratios (CR8) for Gynecological Cancer Diagnostics in 2022
    3.3 Gynecological Cancer Diagnostics Company Evaluation Quadrant
    3.4 Gynecological Cancer Diagnostics Market: Overall Company Footprint Analysis
        3.4.1 Gynecological Cancer Diagnostics Market: Region Footprint
        3.4.2 Gynecological Cancer Diagnostics Market: Company Product Type Footprint
        3.4.3 Gynecological Cancer Diagnostics Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Gynecological Cancer Diagnostics Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Gynecological Cancer Diagnostics Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Gynecological Cancer Diagnostics Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Gynecological Cancer Diagnostics Consumption Value Comparison
        4.2.1 United States VS China: Gynecological Cancer Diagnostics Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Gynecological Cancer Diagnostics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Gynecological Cancer Diagnostics Companies and Market Share, 2018-2023
        4.3.1 United States Based Gynecological Cancer Diagnostics Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Gynecological Cancer Diagnostics Revenue, (2018-2023)
    4.4 China Based Companies Gynecological Cancer Diagnostics Revenue and Market Share, 2018-2023
        4.4.1 China Based Gynecological Cancer Diagnostics Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Gynecological Cancer Diagnostics Revenue, (2018-2023)
    4.5 Rest of World Based Gynecological Cancer Diagnostics Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Gynecological Cancer Diagnostics Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Gynecological Cancer Diagnostics Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Gynecological Cancer Diagnostics Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Genetic Counseling Test
        5.2.2 Cancer Risk Test
        5.2.3 Kits Test
    5.3 Market Segment by Type
        5.3.1 World Gynecological Cancer Diagnostics Market Size by Type (2018-2023)
        5.3.2 World Gynecological Cancer Diagnostics Market Size by Type (2024-2029)
        5.3.3 World Gynecological Cancer Diagnostics Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Gynecological Cancer Diagnostics Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Gestational Trophoblastic Disease Diagnostics
        6.2.2 Endometrial Cancer Diagnostics
        6.2.3 Peritoneal Cancer Diagnostics
        6.2.4 Cervical Cancer Diagnostics
        6.2.5 Cervical Cancer Diagnostics
        6.2.6 Vaginal Cancer Diagnostics
        6.2.7 Uterine Cancer Diagnostics
        6.2.8 Vulvar Cancer Diagnostics
    6.3 Market Segment by Application
        6.3.1 World Gynecological Cancer Diagnostics Market Size by Application (2018-2023)
        6.3.2 World Gynecological Cancer Diagnostics Market Size by Application (2024-2029)
        6.3.3 World Gynecological Cancer Diagnostics Market Size by Application (2018-2029)

7 Company Profiles
    7.1 UT Southwestern
        7.1.1 UT Southwestern Details
        7.1.2 UT Southwestern Major Business
        7.1.3 UT Southwestern Gynecological Cancer Diagnostics Product and Services
        7.1.4 UT Southwestern Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 UT Southwestern Recent Developments/Updates
        7.1.6 UT Southwestern Competitive Strengths & Weaknesses
    7.2 Abramson Cancer Center
        7.2.1 Abramson Cancer Center Details
        7.2.2 Abramson Cancer Center Major Business
        7.2.3 Abramson Cancer Center Gynecological Cancer Diagnostics Product and Services
        7.2.4 Abramson Cancer Center Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Abramson Cancer Center Recent Developments/Updates
        7.2.6 Abramson Cancer Center Competitive Strengths & Weaknesses
    7.3 Northwestern Medicine
        7.3.1 Northwestern Medicine Details
        7.3.2 Northwestern Medicine Major Business
        7.3.3 Northwestern Medicine Gynecological Cancer Diagnostics Product and Services
        7.3.4 Northwestern Medicine Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Northwestern Medicine Recent Developments/Updates
        7.3.6 Northwestern Medicine Competitive Strengths & Weaknesses
    7.4 Sysmex Europe SE
        7.4.1 Sysmex Europe SE Details
        7.4.2 Sysmex Europe SE Major Business
        7.4.3 Sysmex Europe SE Gynecological Cancer Diagnostics Product and Services
        7.4.4 Sysmex Europe SE Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Sysmex Europe SE Recent Developments/Updates
        7.4.6 Sysmex Europe SE Competitive Strengths & Weaknesses
    7.5 Fujirebio
        7.5.1 Fujirebio Details
        7.5.2 Fujirebio Major Business
        7.5.3 Fujirebio Gynecological Cancer Diagnostics Product and Services
        7.5.4 Fujirebio Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Fujirebio Recent Developments/Updates
        7.5.6 Fujirebio Competitive Strengths & Weaknesses
    7.6 Premier Health
        7.6.1 Premier Health Details
        7.6.2 Premier Health Major Business
        7.6.3 Premier Health Gynecological Cancer Diagnostics Product and Services
        7.6.4 Premier Health Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Premier Health Recent Developments/Updates
        7.6.6 Premier Health Competitive Strengths & Weaknesses
    7.7 Agilent Technologies, Inc
        7.7.1 Agilent Technologies, Inc Details
        7.7.2 Agilent Technologies, Inc Major Business
        7.7.3 Agilent Technologies, Inc Gynecological Cancer Diagnostics Product and Services
        7.7.4 Agilent Technologies, Inc Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Agilent Technologies, Inc Recent Developments/Updates
        7.7.6 Agilent Technologies, Inc Competitive Strengths & Weaknesses
    7.8 ARUP Laboratories
        7.8.1 ARUP Laboratories Details
        7.8.2 ARUP Laboratories Major Business
        7.8.3 ARUP Laboratories Gynecological Cancer Diagnostics Product and Services
        7.8.4 ARUP Laboratories Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 ARUP Laboratories Recent Developments/Updates
        7.8.6 ARUP Laboratories Competitive Strengths & Weaknesses
    7.9 CENTOGENE
        7.9.1 CENTOGENE Details
        7.9.2 CENTOGENE Major Business
        7.9.3 CENTOGENE Gynecological Cancer Diagnostics Product and Services
        7.9.4 CENTOGENE Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 CENTOGENE Recent Developments/Updates
        7.9.6 CENTOGENE Competitive Strengths & Weaknesses
    7.10 F. Hoffmann-La Roche Ltd
        7.10.1 F. Hoffmann-La Roche Ltd Details
        7.10.2 F. Hoffmann-La Roche Ltd Major Business
        7.10.3 F. Hoffmann-La Roche Ltd Gynecological Cancer Diagnostics Product and Services
        7.10.4 F. Hoffmann-La Roche Ltd Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
        7.10.6 F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
    7.11 Fulgent Genetics, Inc
        7.11.1 Fulgent Genetics, Inc Details
        7.11.2 Fulgent Genetics, Inc Major Business
        7.11.3 Fulgent Genetics, Inc Gynecological Cancer Diagnostics Product and Services
        7.11.4 Fulgent Genetics, Inc Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Fulgent Genetics, Inc Recent Developments/Updates
        7.11.6 Fulgent Genetics, Inc Competitive Strengths & Weaknesses
    7.12 Invitae Corporation
        7.12.1 Invitae Corporation Details
        7.12.2 Invitae Corporation Major Business
        7.12.3 Invitae Corporation Gynecological Cancer Diagnostics Product and Services
        7.12.4 Invitae Corporation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Invitae Corporation Recent Developments/Updates
        7.12.6 Invitae Corporation Competitive Strengths & Weaknesses
    7.13 Myriad Genetics, Inc
        7.13.1 Myriad Genetics, Inc Details
        7.13.2 Myriad Genetics, Inc Major Business
        7.13.3 Myriad Genetics, Inc Gynecological Cancer Diagnostics Product and Services
        7.13.4 Myriad Genetics, Inc Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Myriad Genetics, Inc Recent Developments/Updates
        7.13.6 Myriad Genetics, Inc Competitive Strengths & Weaknesses
    7.14 BGI Group
        7.14.1 BGI Group Details
        7.14.2 BGI Group Major Business
        7.14.3 BGI Group Gynecological Cancer Diagnostics Product and Services
        7.14.4 BGI Group Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 BGI Group Recent Developments/Updates
        7.14.6 BGI Group Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Gynecological Cancer Diagnostics Industry Chain
    8.2 Gynecological Cancer Diagnostics Upstream Analysis
    8.3 Gynecological Cancer Diagnostics Midstream Analysis
    8.4 Gynecological Cancer Diagnostics Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Gynecological Cancer Diagnostics Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Gynecological Cancer Diagnostics Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Gynecological Cancer Diagnostics Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Gynecological Cancer Diagnostics Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Gynecological Cancer Diagnostics Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Gynecological Cancer Diagnostics Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Gynecological Cancer Diagnostics Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Gynecological Cancer Diagnostics Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Gynecological Cancer Diagnostics Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Gynecological Cancer Diagnostics Players in 2022
    Table 12. World Gynecological Cancer Diagnostics Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Gynecological Cancer Diagnostics Company Evaluation Quadrant
    Table 14. Head Office of Key Gynecological Cancer Diagnostics Player
    Table 15. Gynecological Cancer Diagnostics Market: Company Product Type Footprint
    Table 16. Gynecological Cancer Diagnostics Market: Company Product Application Footprint
    Table 17. Gynecological Cancer Diagnostics Mergers & Acquisitions Activity
    Table 18. United States VS China Gynecological Cancer Diagnostics Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Gynecological Cancer Diagnostics Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Gynecological Cancer Diagnostics Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Gynecological Cancer Diagnostics Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Gynecological Cancer Diagnostics Revenue Market Share (2018-2023)
    Table 23. China Based Gynecological Cancer Diagnostics Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Gynecological Cancer Diagnostics Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Gynecological Cancer Diagnostics Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Gynecological Cancer Diagnostics Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Gynecological Cancer Diagnostics Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Gynecological Cancer Diagnostics Revenue Market Share (2018-2023)
    Table 29. World Gynecological Cancer Diagnostics Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Gynecological Cancer Diagnostics Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Gynecological Cancer Diagnostics Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Gynecological Cancer Diagnostics Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Gynecological Cancer Diagnostics Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Gynecological Cancer Diagnostics Market Size by Application (2024-2029) & (USD Million)
    Table 35. UT Southwestern Basic Information, Area Served and Competitors
    Table 36. UT Southwestern Major Business
    Table 37. UT Southwestern Gynecological Cancer Diagnostics Product and Services
    Table 38. UT Southwestern Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. UT Southwestern Recent Developments/Updates
    Table 40. UT Southwestern Competitive Strengths & Weaknesses
    Table 41. Abramson Cancer Center Basic Information, Area Served and Competitors
    Table 42. Abramson Cancer Center Major Business
    Table 43. Abramson Cancer Center Gynecological Cancer Diagnostics Product and Services
    Table 44. Abramson Cancer Center Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Abramson Cancer Center Recent Developments/Updates
    Table 46. Abramson Cancer Center Competitive Strengths & Weaknesses
    Table 47. Northwestern Medicine Basic Information, Area Served and Competitors
    Table 48. Northwestern Medicine Major Business
    Table 49. Northwestern Medicine Gynecological Cancer Diagnostics Product and Services
    Table 50. Northwestern Medicine Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Northwestern Medicine Recent Developments/Updates
    Table 52. Northwestern Medicine Competitive Strengths & Weaknesses
    Table 53. Sysmex Europe SE Basic Information, Area Served and Competitors
    Table 54. Sysmex Europe SE Major Business
    Table 55. Sysmex Europe SE Gynecological Cancer Diagnostics Product and Services
    Table 56. Sysmex Europe SE Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Sysmex Europe SE Recent Developments/Updates
    Table 58. Sysmex Europe SE Competitive Strengths & Weaknesses
    Table 59. Fujirebio Basic Information, Area Served and Competitors
    Table 60. Fujirebio Major Business
    Table 61. Fujirebio Gynecological Cancer Diagnostics Product and Services
    Table 62. Fujirebio Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Fujirebio Recent Developments/Updates
    Table 64. Fujirebio Competitive Strengths & Weaknesses
    Table 65. Premier Health Basic Information, Area Served and Competitors
    Table 66. Premier Health Major Business
    Table 67. Premier Health Gynecological Cancer Diagnostics Product and Services
    Table 68. Premier Health Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Premier Health Recent Developments/Updates
    Table 70. Premier Health Competitive Strengths & Weaknesses
    Table 71. Agilent Technologies, Inc Basic Information, Area Served and Competitors
    Table 72. Agilent Technologies, Inc Major Business
    Table 73. Agilent Technologies, Inc Gynecological Cancer Diagnostics Product and Services
    Table 74. Agilent Technologies, Inc Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Agilent Technologies, Inc Recent Developments/Updates
    Table 76. Agilent Technologies, Inc Competitive Strengths & Weaknesses
    Table 77. ARUP Laboratories Basic Information, Area Served and Competitors
    Table 78. ARUP Laboratories Major Business
    Table 79. ARUP Laboratories Gynecological Cancer Diagnostics Product and Services
    Table 80. ARUP Laboratories Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. ARUP Laboratories Recent Developments/Updates
    Table 82. ARUP Laboratories Competitive Strengths & Weaknesses
    Table 83. CENTOGENE Basic Information, Area Served and Competitors
    Table 84. CENTOGENE Major Business
    Table 85. CENTOGENE Gynecological Cancer Diagnostics Product and Services
    Table 86. CENTOGENE Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. CENTOGENE Recent Developments/Updates
    Table 88. CENTOGENE Competitive Strengths & Weaknesses
    Table 89. F. Hoffmann-La Roche Ltd Basic Information, Area Served and Competitors
    Table 90. F. Hoffmann-La Roche Ltd Major Business
    Table 91. F. Hoffmann-La Roche Ltd Gynecological Cancer Diagnostics Product and Services
    Table 92. F. Hoffmann-La Roche Ltd Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. F. Hoffmann-La Roche Ltd Recent Developments/Updates
    Table 94. F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
    Table 95. Fulgent Genetics, Inc Basic Information, Area Served and Competitors
    Table 96. Fulgent Genetics, Inc Major Business
    Table 97. Fulgent Genetics, Inc Gynecological Cancer Diagnostics Product and Services
    Table 98. Fulgent Genetics, Inc Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Fulgent Genetics, Inc Recent Developments/Updates
    Table 100. Fulgent Genetics, Inc Competitive Strengths & Weaknesses
    Table 101. Invitae Corporation Basic Information, Area Served and Competitors
    Table 102. Invitae Corporation Major Business
    Table 103. Invitae Corporation Gynecological Cancer Diagnostics Product and Services
    Table 104. Invitae Corporation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Invitae Corporation Recent Developments/Updates
    Table 106. Invitae Corporation Competitive Strengths & Weaknesses
    Table 107. Myriad Genetics, Inc Basic Information, Area Served and Competitors
    Table 108. Myriad Genetics, Inc Major Business
    Table 109. Myriad Genetics, Inc Gynecological Cancer Diagnostics Product and Services
    Table 110. Myriad Genetics, Inc Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. Myriad Genetics, Inc Recent Developments/Updates
    Table 112. BGI Group Basic Information, Area Served and Competitors
    Table 113. BGI Group Major Business
    Table 114. BGI Group Gynecological Cancer Diagnostics Product and Services
    Table 115. BGI Group Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 116. Global Key Players of Gynecological Cancer Diagnostics Upstream (Raw Materials)
    Table 117. Gynecological Cancer Diagnostics Typical Customers
List of Figure
    Figure 1. Gynecological Cancer Diagnostics Picture
    Figure 2. World Gynecological Cancer Diagnostics Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Gynecological Cancer Diagnostics Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Gynecological Cancer Diagnostics Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Gynecological Cancer Diagnostics Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Gynecological Cancer Diagnostics Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Gynecological Cancer Diagnostics Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Gynecological Cancer Diagnostics Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Gynecological Cancer Diagnostics Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Gynecological Cancer Diagnostics Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Gynecological Cancer Diagnostics Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Gynecological Cancer Diagnostics Revenue (2018-2029) & (USD Million)
    Figure 13. Gynecological Cancer Diagnostics Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Gynecological Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Gynecological Cancer Diagnostics Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Gynecological Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Gynecological Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Gynecological Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Gynecological Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Gynecological Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Gynecological Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Gynecological Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Gynecological Cancer Diagnostics by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Gynecological Cancer Diagnostics Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Gynecological Cancer Diagnostics Markets in 2022
    Figure 27. United States VS China: Gynecological Cancer Diagnostics Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Gynecological Cancer Diagnostics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Gynecological Cancer Diagnostics Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Gynecological Cancer Diagnostics Market Size Market Share by Type in 2022
    Figure 31. Genetic Counseling Test
    Figure 32. Cancer Risk Test
    Figure 33. Kits Test
    Figure 34. World Gynecological Cancer Diagnostics Market Size Market Share by Type (2018-2029)
    Figure 35. World Gynecological Cancer Diagnostics Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 36. World Gynecological Cancer Diagnostics Market Size Market Share by Application in 2022
    Figure 37. Gestational Trophoblastic Disease Diagnostics
    Figure 38. Endometrial Cancer Diagnostics
    Figure 39. Peritoneal Cancer Diagnostics
    Figure 40. Cervical Cancer Diagnostics
    Figure 41. Ovarian Cancer Diagnostics
    Figure 42. Vaginal Cancer Diagnostics
    Figure 43. Uterine Cancer Diagnostics
    Figure 44. Vulvar Cancer Diagnostics
    Figure 45. Gynecological Cancer Diagnostics Industrial Chain
    Figure 46. Methodology
    Figure 47. Research Process and Data Source

Companies Mentioned

UT Southwestern
Abramson Cancer Center
Northwestern Medicine
Sysmex Europe SE
Fujirebio
Premier Health
Agilent Technologies, Inc
ARUP Laboratories
CENTOGENE
F. Hoffmann-La Roche Ltd
Fulgent Genetics, Inc
Invitae Corporation
Myriad Genetics, Inc
BGI Group